Development of patient registry and biorepository to establishment of standard therapy for histiocytosis

Development of patient registry and biorepository to establishment of standard therapy for histiocytosis - Histiocytosis Registry & Biorepository Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061446

Enrollment

300

Registered

2026-05-04

Start date

2025-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

histiocytosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with histiocytosis based on pathological examination, including suspected cases. All age groups, all histiocytic disorders, with no restriction on the date of diagnosis. Patients who have been cured or who are deceased are also eligible. 2) Patients who have provided written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Patients who are judged by the investigators to be inappropriate for inclusion in the study.

Design outcomes

Primary

Measure	Time frame
Collection of clinical information including diagnosis, treatment, clinical course, and outcomes Storage of tissue, blood, and bone marrow specimens DNA extraction and comprehensive genomic analysis including NGS Centralized pathological review	—

Countries

Japan

Contacts

Public ContactAki Sato

The Institute of Medical Science Research Hospital, The University of Tokyo Department of Hematology and Oncology

histio@ims.u-tokyo.ac.jp+81-3-5448-5542

Outcome results